Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

7.50
+0.09001.21%
Volume:243.94K
Turnover:1.84M
Market Cap:160.32M
PE:-1.65
High:7.87
Open:7.21
Low:7.16
Close:7.41
Loading ...

With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns

Simply Wall St.
·
15 Feb

Enanta Pharmaceuticals (ENTA) Moves to Buy: Rationale Behind the Upgrade

Zacks
·
15 Feb

Enanta Pharmaceuticals (ENTA) Receives a Buy from Evercore ISI

TIPRANKS
·
13 Feb

Enanta CEO buys $256K in common stock

TIPRANKS
·
13 Feb

Enanta Pharmaceuticals Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Feb

Enanta Pharmaceuticals (ENTA) Receives a Sell from J.P. Morgan

TIPRANKS
·
11 Feb

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Incyte (INCY), Enanta Pharmaceuticals (ENTA) and Esperion (ESPR)

TIPRANKS
·
11 Feb

Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Tops Revenue Estimates

Zacks
·
11 Feb

Enanta Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Feb

BRIEF-Enanta Pharmaceuticals Inc QTRLY Loss Per Share $1.05

Reuters
·
11 Feb

Enanta Pharmaceuticals Inc: Qtrly Loss per Share $1.05

THOMSON REUTERS
·
11 Feb

Enanta Pharmaceuticals Inc Q1 Shr View $-1.35 -- Lseg Ibes Data

THOMSON REUTERS
·
11 Feb

Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot

Associated Press Finance
·
11 Feb

Enanta Pharma Q1 EPS $(1.05) Beats $(1.35) Estimate, Sales $16.96M Miss $17.25M Estimate

Benzinga
·
11 Feb

Enanta reports Q1 EPS ($1.05), consensus ($1.35)

TIPRANKS
·
11 Feb

BRIEF-Enanta Pharmaceuticals Q1 Revenue USD 16.959 Million

Reuters
·
11 Feb

Enanta Pharmaceuticals Q1 Operating Income USD -23.543 Million

THOMSON REUTERS
·
11 Feb

Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2024

Business Wire
·
11 Feb

Enanta Pharmaceuticals Inc expected to post a loss of $1.35 a share - Earnings Preview

Reuters
·
08 Feb

Enanta Pharmaceuticals Inc expected to post a loss of $1.35 a share - Earnings Preview

Reuters
·
04 Feb